3 Biotech Stocks to Beat the Bear Market

2022 is a challenging year for the market. After battling surging inflation for the first six months, another threat is emerging with rising recession risk. Biotech stocks could be a place where investors can find outperformance given their low valuations and strong long-term fundamentals.

shutterstock.com – StockNews

2022 is likely to go down as one of the most challenging years for investors since 2008. YTD, the S&P 500 is down more than 20%, while there is equal pain in the bond market due to inflation and a hawkish Fed.

However, there are a handful of sectors outperforming over the past few weeks due to

→ Continue reading at Entrepreneur

More from author

Related posts

Advertisment

Latest posts

A bay view with single-level living

Live in this renovated and refined midcentury retreat with bay-and-beyond views.This three-bedroom home with clean lines includes a separated primary suite with a view,...

3 Biotech Stocks to Beat the Bear Market

2022 is a challenging year for the market. After battling surging inflation for the first six months, another threat is emerging with rising recession...

2 ‘Under the Radar’ Autonomous Vehicle Stocks to Buy on the Dip

Autonomous vehicles (AV) are the next major evolutionary step in transportation. However, there are many years before its full adoption. Here are 2 stocks...